CSL Behring Executive Named 2012 Risk Manager of the Year® by Business Insurance Magazine
King of Prussia, PA — 20 April 2012
John J. Marren, director, global risk and insurance management at
CSL Behring, has been named the 2012 Risk Manager of the Year® by Business Insurance magazine.
Marren was selected by an independent panel of judges composed of former honorees and insurance industry executives. The award was presented during the recent Risk & Insurance Management Society's Annual Conference and Exhibition in Philadelphia.
A CSL Behring employee since 2007, Marren’s responsibilities include coordination and oversight of CSL’s Risk Management Process, including risk reporting, risk framework development and implementation, risk management education, and risk management process technology development.
He is also responsible for all corporate property and casualty insurances, as well as global coordination of the health, safety and environment function of CSL Behring. Marren resides in Wayne, PA.
About CSL Behring
CSL Behring is a leader in the plasma protein therapeutics industry. Committed to saving lives and improving the quality of life for people with rare and serious diseases, the company manufactures and markets a range of plasma-derived and recombinant therapies worldwide.
CSL Behring therapies are used around the world to treat coagulation disorders including hemophilia and von Willebrand disease, primary immune deficiencies, hereditary angioedema and inherited respiratory disease. The company’s products are also used in cardiac surgery, organ transplantation, burn treatment and to prevent hemolytic diseases in the newborn.
CSL Behring operates one of the world’s largest plasma collection networks, CSL Plasma. CSL Behring is a subsidiary of
CSL Limited (ASX: CSL), a biopharmaceutical company headquartered in Melbourne, Australia. For more information, visit
www.cslbehring.com or view
CSL Limited’s Corporate Responsibility Report.
Manager, Corporate Communications